Fakhri YOUSEF

6381

Effect of pH on the complexation of irbesartan with β -, hydroxypropyl-β -, and γ -cyclodextrin: solubility enhancement and physicochemical characterization

Effect of pH on the complexation of irbesartan with β -, hydroxypropyl-β -, and γ -cyclodextrin: solubility enhancement and physicochemical characterization

The affinity of irbesartan (IRB) to form inclusion complexes with β -cyclodextrin (β -CD), hydroxypropylβ -cyclodextrin (HP-β -CD), and γ -cyclodextrin (γ -CD) was investigated in aqueous buffered solutions at pH 1.7, 4.1,and 7.0. Analysis of the UV absorption-pH profiles revealed that IRB has two pKa values: pKa1 = 3.60 (imidazolinonering moiety) and pKa2 = 4.70 (tetrazole moiety). In the presence of 5.0 mmol L −1β -CD, the tetrazole moiety becamemore acidic, indicating its inclusion within the β -CD cavity. Phase-solubility diagrams (PSDs) were obtained for IRBin aqueous buffered solutions of β -CD, HP-β -CD, and γ -CD at pH 4.1 (zwitterionic IRB), pH 1.7 (protonated IRB),and pH 7.0 (deprotonated IRB). Rigorous nonlinear regression analysis of IRB/CD PSDs at pH 4.1, where IRB is poorlysoluble, yielded estimates of complex formation constants (K11) that followed the decreasing order of HP-β -CD >γ -CD>β -CD. The highest solubility enhancement of IRB was achieved by complexation with HP-β -CD at pH 4.1. Theformation of the IRB/β -CD inclusion complex in solution and in the solid state has been proven through NMR, DSC,FT-IR, and XRD studies. Analysis of 1 H and 13 C-NMR spectra indicated the inclusion of the tetrazole-biphenyl moietywithin the β -CD cavity.
PDF

___

  • 1. Wu, J.; Ding, W.; Zhao, J.; Zang, W.; Matsuura, H.; Horie, M. J. Renin Angiotensin Aldosterone Syst. 2013, 15, 341-347.
  • 2. Vanderheyden, P.; Verheijen, I.; Fierens, F.; De Backer, J.; Vauquelin, G. J. Renin Angiotensin Aldosterone Syst. 2000, 1, 159-165.
  • 3. Weber, M. A. J. Renin Angiotensin Aldosterone Syst. 2003, 4, 62-73.
  • 4. Brunetti, N. D.; De Gennaro, L.; Pellegrino, P. L.; Cuculo, A.; Ziccardi, L.; Gaglione, A.; Di Biase, M. Eur. J. Cardiovasc. Prev. Rehabil. 2011, 18, 424-437.
  • 5. Ranjita, S. J. Pharm. Investig. 2013, 43, 1-26.
  • 6. Takahashi, A. I.; Veiga, F. J. B.; Ferraz, H. G. Int. J. Pharm. Sci. Rev. Res. 2012, 12, 1-7.
  • 7. Earle, R. R.; Tedlapu, V. K.; Ayalasomayajula, L. U. Res. J. Pharm. Technol. 2017, 10, 301-306.
  • 8. Hirlekar, R.; Kadam, V. AAPS PharmSciTech 2009, 10, 276-281.
  • 9. Kane, R.; Naik, S.; Bumrela, S.; Kuchekar, B. J. Pharm. Res. 2009, 2, 1359-1364.
  • 10. Hirlekar, R. S.; Sonawane, S. N.; Kadam, V. J. AAPS PharmSciTech 2009, 10, 858-863.
  • 11. Muankaew, C.; Jansook, P.; Stefansson, E.; Loftsson, T. Int. J. Pharm. 2014, 474, 80-90.
  • 12. Tosco, P.; Rolando, B.; Fruttero, R.; Henchoz, Y.; Martel, S.; Carrupt, P.; Gasco, A. Helv. Chim. Acta 2008, 91, 468-482.
  • 13. Cagigal, E.; Gonzalez, L.; Alonso, R. M.; Jimenez, R. M. J. Pharm. Biomed. Anal. 2001, 26, 477-486.
  • 14. Brewster, M. E.; Loftsson, T. Adv. Drug Deliv. Rev. 2007, 59, 645-666.
  • 15. Liu, L.; Guo, Q. X. J. Incl. Phenom. Macrocycl. Chem. 2002, 42, 1-14.
  • 16. Bauer, M.; Harris, R. K.; Rao, R. C.; Apperley, D. C.; Rodger, C. A. J. Chem. Soc. Perkin Trans. 1998, 2, 475-481.
  • 17. Byard, S. J.; Herbert, J. M. Tetrahedron 1999, 55, 5931-5936.
  • 18. Bettinetti, G.; Novák, C.; Sorrenti, M. J. Therm. Anal. Calorim. 2002, 68, 517-529.
  • 19. Franca, C. A.; Etcheverry, S. B.; Diez, R. P.; Williams, P. A. M. J. Raman Spectrosc. 2009, 40, 1296-1300.
  • 20. Al Omari, M. M.; Zughul, M. B.; Davies, J. E. D.; Badwan, A. A. J. Pharm. Biomed. Anal. 2006, 41, 857-865.
  • 21. Higuchi, T.; Connors, A. In Advances in Analytical Chemistry and Instrumentation Vol. 4; Reilley, C. N., Ed. Interscience Publishers: Hoboken, NJ, USA, 1964, pp. 117-211.
  • 22. Zughul, M. B.; Badwan, A. A. J. Incl. Phenom. Mol. Recognit. Chem. 1998, 31, 243-264.
  • 23. Zughul, M. B. J. Incl. Phenom. Macrocycl. Chem. 2007, 57, 525-530.
  • 24. Cappello, B.; Maio, C.; Iervolino, M.; Miro, A. J. Incl. Phenom. Macrocycl. Chem. 2006, 54, 289-294.
Turkish Journal of Chemistry-Cover
  • ISSN: 1300-0527
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Arşiv
Sayıdaki Diğer Makaleler

Ülkü YILMAZ, Hasan KÜÇÜKBAY

Synthesis and antimicrobial and antioxidant activities of hybrid molecules containing benzotriazole and 1,2,4-triazole

Mahesh CHAND, Reena KAUSHIK, Subhash CHAND JAIN

Synthesis of acetamide derivatives of 1,2,4-triazole bearing azinane and their binding interactions with bovine serum albumin using spectroscopic techniques

Hira KHALID, Javed IQBAL, Aziz UR-REHMAN, Muhammad Athar ABBASI, Sabahat Zahra SIDDIQUI, Sabina Jhaumeer LAULLOO, Nausheen JOONDAN, Aniisah Banu TAUPASS, Shahid RASOOL, Syed Adnan Ali SHAH

Seyed-abolfazl MOHTASHAMI, Neda Asasian KOLUR, Tahereh KAGHAZCHI, Reza ASADI-KESHEH, Mansooreh SOLEIMANI

Zhenbo LIU, Tangmi YUAN, Yongming LIU, Wenzuo LI, Qingzhong LI, BO XIAO, Jianbo CHENG

Synergetic effect of Mn, Ce, Ba, and B modification and moderate desilication of nanostructured HZSM-5 catalyst on conversion of methanol to propylene

Fatemeh YAHYAZADEH SARAVI, Majid TAGHIZADEH

Fatemeh Yahyazadeh SARAVI, Majid TAGHIZADEH

Maher CHERIF, Mariem DEBBABI, Sarra CHORTANI, Anis ROMDHANE, Hichem Ben JANNET

Exploring inhibition of chemiluminescence mechanisms with fluorescence quenching studies and interaction energy calculations

Bo XIAO, Zhenbo LIU, Tangmi YUAN, Yongming LIU, Wenzuo LI, Qingzhong LI, Jianbo CHENG

Synthesis, spectroscopic characterization, and computational studies of 2-cyano-6-hydroxybenzothiazole: a key synthetic intermediate of firefly luciferin

Ghasem SHAHMORADI, Saeid AMANI